How Phosphorus in Diet Affects Calcium and Phosphorus Balance in Kidney Disease
Part of Hormones & metabolism, Kidney & urinary clinical trials.
This study looks at how the amount of phosphorus you eat affects your body's balance of phosphorus and calcium. It may help people with moderate kidney disease better understand how diet and mineral levels interact.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 30 and 75 years old.
- You have moderate chronic kidney disease (stages 3b or 4).
- Your parathyroid hormone (PTH) level is above normal.
- You are not taking phosphate binders, calcitriol, or similar medications.
- You can stop taking calcium, vitamin D, and other supplements during the study.
- You have adequate vitamin D levels (above 20 ng/mL).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how replacing high-protein foods affects people with chronic kidney disease. If you join, you will eat a carefully controlled diet to help researchers understand if changing your protein intake can improve your kidney health.
This study looks at how the body handles phosphate in people with chronic kidney disease. It may help researchers understand how to better manage phosphate levels to improve health.
This trial tests whether regulating parathyroid hormone (PTH) can improve bone density in people with advanced chronic kidney disease (CKD) who are not on dialysis. It may help you if you have stage 4-5 CKD and high PTH levels.
This study measures how your body handles extra phosphate in the diet and whether this changes with your age and gender. It may help doctors understand more about bone and kidney health.
This study tests whether a new medicine called TS-172 can help lower phosphorus levels in patients on peritoneal dialysis (a type of kidney treatment). High phosphorus can cause bone problems and other complications, so the trial aims to see if this drug works better than current treatments.
This trial tests a program to help hemodialysis patients better understand phosphorus control and stick to their phosphate-binding medications. It aims to improve health outcomes by supporting patients who have been on dialysis for over a year.
Hear when a new CKD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.